ScienceDex / Researcher record
Fanger, Michael W
- Celdara Medical, LLC (no department on record)
From the FY2012 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Top 10% Funded
NIH Funding · FY2012
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2010 | $391,529 | 1 | #21,407 |
| 2011 | $1,283,265 | 2 | #5,177 |
| 2012 | $3,146,123 | 3 | #1,368 |
| 2013 | $3,105,914 | 3 | #1,316 |
| 2014 | $1,540,723 | 4 | #3,997 |
| 2015 | $1,599,869 | 2 | #3,787 |
| 2016 | $733,811 | 1 | #10,280 |
| 2017 | $225,000 | 1 | #30,445 |
| 2019 | $524,168 | 2 | #18,640 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20101 record
- FY20112 records
- FY2012 · selected3 records
- FY20133 records
- FY20144 records
- FY20152 records
- FY20161 record
- FY20171 record
- FY20192 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2010 through FY2019Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2012 award records by amount
NIH award records listing Fanger, Michael W as a PI. Multi-PI records show the full award amount for context.
- 2R44HL099217-02A1R44Contact PIChNKG2D-Targeted Cellular Cancer Therapy: Phase I Clinical Trial$1.4Maward amount
- 2R44HL097464-02A1R44Contact PIDepletion of Dendritic Cells by Immunotoxin as Therapy for Myocardial Infarction$1.1Maward amount
- 1R43HL112361-01A1R43Contact PIPreclinical Development of a Novel Plaque-Regressing Therapy For Atherosclerosis$675.9Kaward amount
Award organization
Organizations that administered FY2012 awards listing Fanger, Michael W as a PI.
FY2012 award administered by Celdara Medical, LLC (NH).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2010First NIH AwardCeldara Medical, LLC
- 2011$500K Cumulative Funding
- 2011$1M Cumulative Funding
- 2011Entered Top 50% NationallyRanked #5177
- 2012$2M Cumulative Funding
- 2012Entered Top 25% NationallyRanked #1368
- 2012Entered Top 10% NationallyRanked #1368
- 2013$5M Cumulative Funding
- 2015$10M Cumulative Funding